irvine, california, August 16, 2022 /PRNewswire/ — Lotus Bio-Technologies Development Corp. (OTC:LBTD) today announced that it has begun the process of changing its name from Lotus Bio-Technology Development Corp. to Boomerang Corporation.
Regarding the name change, the representative director Hoyt Christopher “This new name more closely reflects the friendly and personalized nature of our current and future business models, which are intended to empower users by making their healthcare easily accessible, customizable, and controllable. It reflects.”
Boomerang has a similar business model to EverlyWell (currently valued at $2.9 billion) and Hims & Hers, Inc. (currently valued at $1.2 billion). Boomerang provides test kits containing self-collecting sample devices directly to users. The user then sends the sample back to one of Boomerang’s labs via a return label for testing and not only receives the results digitally, but also a custom his wellness plan based on the results. Boomerang currently offers tests in support of men’s health, women’s health, sexual health, and COVID-19.
About Boomerang:
Boomerang sees an opportunity to revolutionize healthcare by bringing diagnostic tests to the comfort of their own home and empowering users with powerful pathways based on their results. Through state-of-the-art at-home diagnostic tests, customizable wellness plans, and strategic partnerships, Boomerang is uniquely positioned to become a leader in the fast-growing multi-billion dollar digital health market.
For more information about the company, please visit boomerangkit.com.
Safe Harbor Declaration: This press release includes: “Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to differ. , these forward-looking statements.
Readers are urged to carefully review and consider the various disclosures made by LBTD in its reports filed with the Securities and Exchange Commission. This includes risk factors that seek to inform our stakeholders of risks that may affect our business, financial condition and results of operations. and cash flow. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results could differ materially from those expected or projected. there is. Readers are urged not to place undue reliance on these forward-looking statements. These statements are made only as of the date of this release. We undertake no obligation to update any forward-looking statements to reflect events or circumstances that may occur after the date of this release.
contact:
David Otestadcreative director
Email: ir@boomerandgkit.com
View original content: https://www.prnewswire.com/news-releases/lotus-bio-technology-development-corp-inc-initiates-company-name-change-301607074.html
SOURCE Boomerang Corporation
.
Comments
Post a Comment